10-71675131-G-C

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBA1

The NM_022124.6(CDH23):​c.1469G>C​(p.Gly490Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.175 in 1,613,382 control chromosomes in the GnomAD database, including 27,778 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 2218 hom., cov: 32)
Exomes 𝑓: 0.18 ( 25560 hom. )

Consequence

CDH23
NM_022124.6 missense

Scores

3
8
5

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:12

Conservation

PhyloP100: 8.78
Variant links:
Genes affected
CDH23 (HGNC:13733): (cadherin related 23) This gene is a member of the cadherin superfamily, whose genes encode calcium dependent cell-cell adhesion glycoproteins. The encoded protein is thought to be involved in stereocilia organization and hair bundle formation. The gene is located in a region containing the human deafness loci DFNB12 and USH1D. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this cadherin-like gene. Upregulation of this gene may also be associated with breast cancer. Alternative splice variants encoding different isoforms have been described. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

PM1
In a domain Cadherin 5 (size 100) in uniprot entity CAD23_HUMAN there are 6 pathogenic changes around while only 2 benign (75%) in NM_022124.6
BP4
Computational evidence support a benign effect (MetaRNN=0.0017164052).
BP6
Variant 10-71675131-G-C is Benign according to our data. Variant chr10-71675131-G-C is described in ClinVar as [Benign]. Clinvar id is 45872.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-71675131-G-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.287 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDH23NM_022124.6 linkc.1469G>C p.Gly490Ala missense_variant Exon 15 of 70 ENST00000224721.12 NP_071407.4 Q9H251-1Q6P152
CDH23NM_001171930.2 linkc.1469G>C p.Gly490Ala missense_variant Exon 15 of 32 NP_001165401.1 Q9H251A0A087WYR8Q6P152
CDH23NM_001171931.2 linkc.1469G>C p.Gly490Ala missense_variant Exon 15 of 26 NP_001165402.1 Q9H251Q8N5B3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDH23ENST00000224721.12 linkc.1469G>C p.Gly490Ala missense_variant Exon 15 of 70 5 NM_022124.6 ENSP00000224721.9 Q9H251-1

Frequencies

GnomAD3 genomes
AF:
0.147
AC:
22325
AN:
152118
Hom.:
2215
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0332
Gnomad AMI
AF:
0.158
Gnomad AMR
AF:
0.135
Gnomad ASJ
AF:
0.184
Gnomad EAS
AF:
0.299
Gnomad SAS
AF:
0.296
Gnomad FIN
AF:
0.336
Gnomad MID
AF:
0.156
Gnomad NFE
AF:
0.165
Gnomad OTH
AF:
0.136
GnomAD3 exomes
AF:
0.200
AC:
49916
AN:
248990
Hom.:
5877
AF XY:
0.206
AC XY:
27845
AN XY:
135090
show subpopulations
Gnomad AFR exome
AF:
0.0299
Gnomad AMR exome
AF:
0.168
Gnomad ASJ exome
AF:
0.177
Gnomad EAS exome
AF:
0.303
Gnomad SAS exome
AF:
0.288
Gnomad FIN exome
AF:
0.331
Gnomad NFE exome
AF:
0.171
Gnomad OTH exome
AF:
0.195
GnomAD4 exome
AF:
0.178
AC:
260141
AN:
1461146
Hom.:
25560
Cov.:
32
AF XY:
0.182
AC XY:
132038
AN XY:
726832
show subpopulations
Gnomad4 AFR exome
AF:
0.0278
Gnomad4 AMR exome
AF:
0.165
Gnomad4 ASJ exome
AF:
0.181
Gnomad4 EAS exome
AF:
0.302
Gnomad4 SAS exome
AF:
0.286
Gnomad4 FIN exome
AF:
0.323
Gnomad4 NFE exome
AF:
0.164
Gnomad4 OTH exome
AF:
0.172
GnomAD4 genome
AF:
0.147
AC:
22342
AN:
152236
Hom.:
2218
Cov.:
32
AF XY:
0.158
AC XY:
11779
AN XY:
74446
show subpopulations
Gnomad4 AFR
AF:
0.0332
Gnomad4 AMR
AF:
0.135
Gnomad4 ASJ
AF:
0.184
Gnomad4 EAS
AF:
0.299
Gnomad4 SAS
AF:
0.297
Gnomad4 FIN
AF:
0.336
Gnomad4 NFE
AF:
0.165
Gnomad4 OTH
AF:
0.142
Alfa
AF:
0.159
Hom.:
1674
Bravo
AF:
0.125
TwinsUK
AF:
0.174
AC:
644
ALSPAC
AF:
0.169
AC:
651
ESP6500AA
AF:
0.0354
AC:
149
ESP6500EA
AF:
0.164
AC:
1387
ExAC
AF:
0.199
AC:
24132
Asia WGS
AF:
0.308
AC:
1071
AN:
3476
EpiCase
AF:
0.165
EpiControl
AF:
0.164

ClinVar

Significance: Benign
Submissions summary: Benign:12
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided

- -

Mar 03, 2015
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not specified Benign:2
Jun 09, 2009
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Usher syndrome type 1D Benign:2
Jul 01, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Autosomal recessive nonsyndromic hearing loss 12 Benign:2
Jul 01, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Autosomal recessive nonsyndromic hearing loss 12;C1832845:Usher syndrome type 1D;C4539685:Pituitary adenoma 5, multiple types Benign:1
Sep 01, 2021
Fulgent Genetics, Fulgent Genetics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Usher syndrome type 1 Benign:1
Feb 26, 2021
Natera, Inc.
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Retinitis pigmentosa-deafness syndrome Benign:1
May 28, 2019
Mendelics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.35
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Uncertain
-0.010
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.17
T;T;T;.;T;.
Eigen
Pathogenic
0.89
Eigen_PC
Pathogenic
0.84
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.95
D;D;D;D;D;D
MetaRNN
Benign
0.0017
T;T;T;T;T;T
MetaSVM
Benign
-1.2
T
MutationAssessor
Uncertain
2.4
.;.;M;.;.;.
PrimateAI
Uncertain
0.65
T
REVEL
Uncertain
0.41
Sift4G
Uncertain
0.036
D;D;.;D;D;.
Polyphen
1.0
.;.;D;.;.;.
Vest4
0.70
ClinPred
0.011
T
GERP RS
5.7
Varity_R
0.60
gMVP
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1227049; hg19: chr10-73434888; COSMIC: COSV54924856; API